Harrow, Inc. Inventory
Harrow, Inc. (HROW) had Inventory of $16.91 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-10
- 2026-06-30: Inventory, Net $16.91M.
- 2026-03-31: Inventory, Net $16.50M.
- 2025-12-31: Inventory, Net $13.52M.
- 2025-09-30: Inventory, Net $12.83M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $16.91M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $16.50M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $13.52M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $12.83M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $11.55M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $10.72M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $10.70M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $10.16M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $9.43M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $10.81M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $10.87M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $8.92M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $8.55M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $9.09M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $6.54M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $5.28M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.13M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $4.40M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $4.22M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $3.92M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $3.90M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $4.50M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $3.96M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $3.97M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.84M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.99M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.30M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $2.44M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $2.65M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.39M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.83M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $2.52M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $2.22M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $2.04M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.25M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $2.37M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.83M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $2.04M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.84M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $1.90M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.44M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.23M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.41M 10-K · filed 2017-03-21 | |
| 2015-09-30 | $1.27M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $793.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $711.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $373.00K 10-K · filed 2016-03-23 | $372.74K 10-K · filed 2015-03-12 |
| 2014-09-30 | $351.20K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $172.75K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |